NHS England to offer artificial pancreas systems to thousands with type 1 diabetes in groundbreaking move – Diabetes UK

NHS England has announced that thousands of people with type 1 diabetes will soon have access to artificial pancreas systems, a groundbreaking development that could revolutionize the way the condition is managed.

The artificial pancreas system, also known as a closed-loop system, is designed to automatically monitor blood sugar levels and deliver insulin as needed, mimicking the function of a healthy pancreas. This can help individuals with type 1 diabetes maintain more stable blood sugar levels and reduce their risk of complications.

Diabetes UK has welcomed the news, calling it a “game-changer” for people with type 1 diabetes. Chief Executive Chris Askew stated, “This technology has the potential to transform the lives of thousands of people with type 1 diabetes, giving them greater freedom and flexibility in managing their condition.”

The announcement comes after successful trials of the artificial pancreas system in the UK, which showed significant improvements in blood sugar control and quality of life for participants. NHS England plans to roll out the technology to thousands of eligible patients over the next few years.

Dr Partha Kar, NHS England’s National Specialty Advisor for Diabetes, highlighted the importance of this advancement in diabetes care. “This is a major step forward in the treatment of type 1 diabetes, offering patients a more convenient and effective way to manage their condition,” he said.

Overall, the introduction of artificial pancreas systems in the NHS represents a significant milestone in diabetes care and offers hope for a brighter future for those living with type 1 diabetes.